The administration of intravenous gadolinium-containing contrast media was historically considered safe in patients with impaired renal function. This changed in 2006 when the FDA first reported the ...

The arrhythmogenic right ventricular cardiomyopathy (ARVC) risk calculator estimates the risk of incident sustained ventricular arrhythmia (VA) and performs well in ARVC populations meeting 2010 Task ...

Gadolinium-based contrast agents (GBCAs) revolutionized magnetic resonance imaging when introduced in the 1980s, providing clinicians with exceptional clarity in visualizing soft tissue pathology ...

Background Identifying significant coronary artery disease (CAD) in patients with reduced left ventricular ejection fraction (rLVEF) is essential for guiding therapeutic decisions, including medical ...

Scientists have acquired direct evidence of rare, pulsing pear-shaped structures within atomic nuclei of the rare-earth element Gadolinium, thanks to new research. For the first time, scientists have ...

Over my 4 decades living with multiple sclerosis (MS), I’ve had dozens of magnetic resonance imaging (MRI) exams. Almost all of them were done using a contrast agent (often called a dye) containing ...

There have been links between MRI signal changes in the brain and gadolinium deposits from contrast dyes used in scans. Currently, there have not been any proven clinical consequences from gadolinium ...

The authors have no conflicts of interest to disclose. Gadolinium-based contrast agents (GBCA) have played a pivotal role in enhancing the diagnostic capabilities of MRI for several decades. The ...

Abstract: The effects of sputtering conditions on the magnetic and magnetooptic properties of bismuth-substituted gadolinium-iron-garnet (GdIG) films were studied. GdIG films with uniaxial ...

Their analysis is published in the journal Frontiers of Environmental Science & Engineering on December 20, 2023. The coronavirus disease (COVID-19) pandemic has triggered a major increase in the use ...

Effective February 1, 2022, research MRI scans involving Gadolinium contrast agents (GBCA) will follow identical screening and administration policies as JHMI clinical MRI. These guidelines can be ...